Cigna Corp.
https://www.cigna.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Cigna Corp.
Cigna Eyes Biosimilars Competing With 25% Of ‘Specialty’ Products
Ahead of adding Humira (adalimumab) biosimilars to its national preferred formulary from 1 February, Cigna spoke about the potential and opportunity of biosimilar competition in the US, which lags behind other OECD member countries.
Pfizer Reveals Secret Digital Sauce To Cut Trial Duration, MLR Review Times
How do you send 90,000 employees home and still bring a COVID-19 vaccine to market in record time? Pfizer showed the way and at a recent virtual event, senior vice-president Robert Brown revealed how the "secret sauce" of digitalization continues to help cut medical legal review times, crunch clinical trial duration and reduce service interruptions.
Pfizer Reveals Secret Digital Sauce To Cut Trial Duration, MLR Review Times
How do you send 90,000 employees home and still bring a COVID-19 vaccine to market in record time? Pfizer showed the way and at a recent virtual event, senior vice-president Robert Brown revealed how the "secret sauce" of digitalization continues to help cut medical legal review times, crunch clinical trial duration and reduce service interruptions.
PBM Formulary Exclusions On The Rise, PhRMA Says
According to a report commissioned by PhRMA, the three largest pharmacy benefit managers continue to exclude more drugs from standard formularies, including those with expedited FDA approval.
Company Information
- Industry
- Pharmaceuticals
- Services
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice